ArticleCommunications biology2026
Oocyte-specific acylglycerol kinase loss leads to infertility in mice via mitochondrial dysfunction.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The orderly architecture and energy supply of mitochondria, orchestrated by proteins, are essential for oocyte maturation. Acylglycerol kinase (AGK) is known to predominantly localize to the mitochondrial membrane and regulate multiple cellular processes related to Sengers syndrome and tumorigenesis. However, the functions of AGK in the ovaries remain largely unknown. Here, we generate mice with oocyte-specific disruption of Agk. Ablation of Agk in oocytes causes ovarian atrophy characterized by the arrest of early secondary follicles and a significantly reduced number of mature follicles, ultimately leading to female sterility. Furthermore, mitochondria in Agk-deficient oocytes exhibit significant structural and organizational defects. The developmental competence of Agk-deficient oocytes is compromised with decreased mitochondrial membrane potential, reduced mtDNA copy number, impaired ATP synthesis, and elevated reactive oxygen species. Mechanistically, single-cell RNA sequencing shows that genes associated with the mitochondrial oxidative phosphorylation (OXPHOS) pathway are among the most significantly downregulated in Agk-disrupted oocytes. Spatial metabolomics further identifies a substantial reduction in phosphate-associated metabolites linked to the OXPHOS pathway in Agk-deficient oocytes. These findings demonstrate that AGK plays an essential role in oocyte development and folliculogenesis by maintaining mitochondrial function. The present study identifies AGK as a potential diagnostic marker and therapeutic target for female infertility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.